Clinical Trials Directory

Trials / Unknown

UnknownNCT03162185

Serotonin and Motor Plasticity

The Effects of Serotonergic Challenge on Motor Learning and Neuroplasticity

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Max Planck Institute for Human Cognitive and Brain Sciences · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

With this study, the investigators aim to test whether acute administration of selective serotonin reuptake inhibitors (SSRI) improves motor performance in a sequential motor learning task in comparison to placebo in healthy humans.

Detailed description

Microdialysis findings in animal models provide evidence for a monoaminergic augmentation of motor function. However, this evidence is largely limited to noradrenaline and dopamine, with little evidence to support a similar effect for serotonin. What remains to be tested therefore, is whether acute serotonergic administration induces neural or behavioral changes during motor learning also. Using a sample of 60 female participants (with the possible inclusion of male participants at a later date), the investigators aim to test the effects of a serotonergic challenge on motor learning and plasticity in healthy participants.

Conditions

Interventions

TypeNameDescription
DRUGEscitalopramExperimental group participants (n = 30) will receive 20 mg of Escitalopram for 7 days.
DRUGPlaceboControl group participants (n = 30) will receive a placebo for 7 days.

Timeline

Start date
2017-04-01
Primary completion
2017-11-30
Completion
2017-11-30
First posted
2017-05-22
Last updated
2017-05-22

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03162185. Inclusion in this directory is not an endorsement.

Serotonin and Motor Plasticity (NCT03162185) · Clinical Trials Directory